Smith-Magenis syndrome (SMS) is a multiple congenital anomalies/mental retardation syndrome associated with an interstitial deletion of chromosome 17 involving band p11.2. SMS is hypothesised to be a contiguous gene syndrome in which the phenotype arises from the haploinsufficiency of multiple, functionally-unrelated genes in close physical proximity, although the true molecular basis of SMS is not yet known. In this study, we have generated the first overlapping and contiguous transcription map of the SMS critical interval, linking the proximal 17p11.2 region near the SMS-REPM and the distal region near D17S740 in a minimum tiling path of 16 BACs and two PACs. Additional clones provide greater coverage throughout the critical region. Not including the repetitive sequences that flank the critical interval, the map is comprised of 13 known genes, 14 ESTs, and six genomic markers, and is a synthesis of Southern hybridisation and polymerase chain reaction data from gene and marker localisation to BACs and PACs and database sequence analysis from the human genome project high-throughput draft sequence. In order to identify possible candidate genes, we performed sequence analysis and determined the tissue expression pattern analysis of 10 novel ESTs that are deleted in all SMS patients. We also present a detailed review of six promising candidate genes that map to the SMS critical region.
Introduction
Smith-Magenis syndrome (SMS) is a multiple congenital anomalies/mental retardation syndrome associated with an interstitial deletion of chromosome 17 involving band p11.2.
1 ± 3 SMS patients have a recognisable physical pheno-hybridisation (FISH) and somatic rodent : human hybrid cell lines that retain the deleted copy of chromosome 17 have been carried out in order to determine the smallest deletion necessary to give the full SMS phenotype. 7 ± 11 The SMS critical interval' within 17p11.2 is approximately 1.5 ± 2 Mb, and lies between marker D17S29 (centromeric) and cosmid cCI17-638 (telomeric). 7, 8 Haploinsufficiency of one or more genes that lie within the critical interval is likely to be responsible for the SMS phenotype, although the true molecular basis of SMS is not yet known. 8, 12 Recent investigation into the mechanisms for chromosomal rearrangements indicates that genomic regions that are prone to duplications, deletions and inversions are often flanked by chromosome-specific low-copy repeats called duplicons. 13 The repeated regions that flank the SMS common deletion breakpoints within 17p11.2, termed the proximal and distal SMS-REPs (SMS-REPP and SMS-REPD, respectively), span 5200 kb and contain a cluster of at least four genes/pseudogenes. 14 De novo deletions and duplications within the SMS region are likely due to interchromosomal recombination events involving the SMS-REPs. 14, 15 A middle REP (SMS-REPM), that lies within the SMS critical interval, has not yet been shown to promote chromosomal rearrangement, though it is possible that SMS-REPM may be implicated in producing smaller deletions of 17p11.2. Extensive work by our group and others has identified genes and marker loci that map to the SMS critical and common deletion regions within 17p11.2, in order to recognise potential candidate genes for SMS. 8,16 ± 21 This region of 17p11.2 is very gene-rich. Within the critical deletion region, eleven genes have previously been reported: the human homologue of the Drosophila flightless-I gene (FLII); cytosolic serine hydroxymethyltransferase (SHMT1); 21, 23 the human homologue of Drosophila lethal 2 giant larva (LLGL1); 18 topoisomerase IIIa (TOP3A); 19, 24, 25 elongation factor 1a (EEF1A3); 8 sterol regulatory element binding protein 1 (SREBF1); 8 myosin 15 (MYO15A); 26, 27 phosphatidylethanolamine-N-methyltransferase 2 (PEMT2); 8, 20 signalosome subunit 3 of the COP9 signalosome (COP53, SGN3); 28, 29 developmentally-regulated GTP-binding protein 2 (DRG2); 30 and deoxyribonucleotidase-2 (NT5M, formerly dNT-2). 31 Many of these genes have been wellcharacterised and the effect of hemizygosity of several genes has been assessed in a variety of systems; yet there still remains no single excellent candidate gene for the SMS phenotype. 19, 21, 28 A breakpoint region for medulloblastomas (MB) has also been identified within 17p11.2, overlapping the SMS deletion region. 16, 17 This chromosomal region also contains aberrantly methylated CpG islands in association with MBs, although no expression changes due to methylation were found in several ESTs and cDNAs. 32 We now report a physical and transcription map of the SMS critical interval that links the proximal 17p11.2 region near the SMS-REPM and the distal region near D17S740. Not including the repetitive elements that flank the SMS critical interval, this map contains 13 known genes, 14 ESTs, and six anonymous genetic markers.
Materials and methods
Contig construction and analysis BAC/PAC DNA preparation Human California Institute of Technology BAC libraries B-D (hCITB-D) or Roswell Park Cancer Institute library-11 (RPCI-11) BAC and RPCI-1 PAC clones were obtained (Research Genetics, Huntsville, AL, USA or BAC/PAC Resources, Oakland, CA, USA). DNA was isolated using a modification of the Qiagen very low copy protocol (Qiagen Inc., Valencia, CA, USA). Bacteria were grown overnight at 378C on selective antibiotic (12.5 mg/ml chloramphenicol for BACs and 100 mg/ml kanamycin for PACs), then pelleted by spinning at 60006g for 15 min at 48C. Subsequently, 60 ml each of Qiagen Buffers P1, P2, and P3 were added to the pellet and mixed. Tubes were gently inverted, placed on ice for 30 min, and then centrifuged at 48C at 520 0006g. Supernatant containing BAC or PAC DNA was promptly filtered, precipitated with 0.7 volumes of room temperature isopropanol, and centrifuged at 51 50006g for 30 min at 48C. The pelleted DNA was resuspended in 500 ml sterile 16TE, and 5 ml of QBT was added to the BAC/PAC DNA. The BAC/PAC DNA was applied to an equilibrated Qiagen Tip 500 and the Qiagen low copy protocol was then followed according to manufacturer's instructions. Purified BAC/PAC DNA was electrophoresed on a 1% TBE gel, stained with ethidium bromide, visualised on a transilluminator, and quantitated using a UV spectrophotometer (Ultrospec 2000, Pharmacia Biotech, Piscataway, NJ, USA). The SP6 and T7 ends of bc989B15, at the distal end of the critical interval (Figure 1 ), were sequenced by MWG Biotech (MWG Biotech, High Point, NC, USA).
Somatic cell hybrids The somatic cell hybrids utilised for regional mapping to human chromosome 17, including MH22-6, 88H5, LS-1, and 357-2D and the hamster and mouse parental cell lines a23 and Cl-1D (respectively), as well as hybrid cell lines that carry the deleted chromosome 17 from SMS patients, including 147-20D and 484-2D, have been described previously. 9 Hybrid 540-1D, which carries the deleted chromosome 17 from the SMS patient with the smallest reported deletion and hybrid 765-18D, which carries a chromosome 17 with a deletion overlapping the distal portion of the SMS region 17p, have been previously described. 8 tions were performed essentially as described. 7 The blots were exposed to Hyperfilm (Amersham, Piscataway, NJ, USA), with one or two intensifying screens at 7808C.
Database searches Extensive information about the genes/ ESTs in the region ( , and unincorporated nucleotides were removed with a spermine precipitation. The blots were exposed to Hyperfilm (Amersham, Piscataway, NJ, USA) with one or two intensifying screens at 7808C for 2 ± 5 days.
Results
Generation of the SMS critical interval Figure 1 depicts the physical and transcription map of the SMS critical interval. The BACs and PACs within the contig were assembled through a combination of Southern hybridisation, PCR, and HTGS analysis. Initially, known genes, ESTs, and genomic markers that mapped to the critical interval 8 were used to screen a gridded hCITB BAC library in order to form a preliminary contig (data not shown).
Overlapping BACs were identified and grouped according to Alu-PCR fingerprinting and restriction digests (data not shown). In the interest of space, many redundant BACs are not represented in the current contig (data not shown). In order to map markers to the initial contig, known genes and ESTs were hybridised to EcoRI-digested BACs or PCRamplified from BAC DNA. This preliminary contig had many gaps and could not be completed with the BAC resources that were available. We therefore took advantage of human genome project data to improve the coverage of our contig. To date, there remains little finished human genome sequence data for the SMS critical interval except for bc124H2 (which contains WI-11472/NT5M and a portion of COPS3) and sequence generated through MYO15A analysis (GenBank AF051976). This region of 17p is very gene rich but also contains numerous low-copy repeats that may complicate HTGS sequence alignment (Table 2 and Figure 1 ). We used BLAST searches with gene and EST sequence data to identify HTGS RPCI BAC/PAC and CIT BAC data that were pertinent to the SMS critical interval. We subsequently obtained several of these clones for analysis. We also utilised draft sequence alignments from the Golden Path (http://genome.ucsc.edu/ GoldenPath). We searched with BAC-end sequence information from GenBank to establish a minimum tiling path of 16 BACs and two PACs ( Figure 1 ). Several overlapping clones are included in the map to provide greater coverage ( Figure 1 ). Gene order was determined through HTGS sequence analysis and Southern hybridisation for the presence or absence of a TCTAACCCCAAGCAAAGCCACTGC  GAGACCCTGGGATGATAATGGATGG  55  D17S447  GCTCTGGTTCATATTACCCTGACAC  GCTCTCCAGCCTGGGCAACAAGCGTG  55  D17S620  GGGAAGGTGTCTGAAACCCAAGG  CCCACCACTACCTATTGTTCTA  55  D17S740  CTCTTTGTGCTTGGCAGGGT  TACATTTAATGCAGGATGCC  55  D17S1715  GACTGGCAGGGGATAAGTACC  ATCTCTCAAGTGGGGGTCCT  55  D17S2021  TAAAATCAGAGTCGAGAGAAAGTCA  CACACTCAGCAGGATAGAGGC  55  A003A44  GTGACAAAAACACTAAACTTCTA  GGGACGGATATTTATTTC  55  A004R11  GTAAGAGTCAAAAATCTAACAGA  CACTTTATGCAGATTTCC  55  A006R41  CAGAGCATAAGTCCTTTTAA  GACTGTTATTTAACTGAATCAGT  55  A006Y21  TGGTGACTTCCAATCTATATAT  TTACTTTTGACTCACAGTGTTA  52  IB1187  GTATTTTGTACATGTCCATGGG  GATGAACTGCCTTAGCCCAA  52  NIB1041  ATCAACCTGGACATCAAATG  CTGGAAGACAAACAGGAACA  55  stSG8339  AGTGGGAAGGTGTTGAGGG  GTGCCCTGGCATATGAGTG  60  stSG9692  GAGACCAACAGGAACTATT  CTTTGAGAAACATTGAGG  52  T78887  AGACCTCAATAAGCTGTGGG  CCATGAGAATCAGTTTATGCC  55  WI-11472  TTACACACATGAACAGCATTTATTT  TGTGCTGGGGGACGATACT Cosmid genomic clones for several of the genes were identified through hybridisation of EST inserts to gridded filters of the Los Alamos flow-sorted chromosome 17-specific cosmid library. 34 The region from SHMT1 to FLII is wellrepresented by overlapping cosmids, which confirmed gene order (data not shown). 19, 21, 22 We reconciled HTGS data with naturally-occurring deletions by hybridising genes and ESTs to EcoRI-digested rodent:human somatic cell hybrid panel DNA (Figure 2 ). 8 The SMS critical interval is represented by the SMS patient HOU142-540, 7, 8, 10 who carries the smallest deletion described to date. Within the critical interval, we have identified 13 known genes and 14 ESTs. A summary is presented below. Six genomic markers were utilised in the generation of the physical map of the critical region: D17S258 (STS, GDB:178583), D17S740 (CA dinucleotide repeat, GenBank L29354, dbSTS: 3906), D17S1794 (CA dinucleotide repeat, GenBank Z52295, dbSTS: 46953), D17S620 (CA dinucleotide repeat, GenBank L29360, dbSTS: 3170), D17S447 (STS; also called FG2, GDB:186807), and D17S71 (STS, GDB:180951). 7, 8 EST characterisation and analysis Previously, numerous markers were mapped along chromosome 17p11-p12, including short tandem repeats (STRs), sequence-tagged sites (STSs), expressed sequence tags (ESTs), and 12 identified genes. 8 Binning/fine-mapping of ESTs within 17p11.2 was accomplished through PCR, FISH, or Southern hybridisation to DNA from a panel of rodent : human somatic cell hybrids. 8 In this study, plasmid clones for each of the 14 ESTs that mapped to the critical interval were obtained commercially, inserts were sequenced, and extensive database searches of the nucleotide sequence and 6-frame amino acid translation were conducted in order to identify homologous genes and sequence motifs ( Table 2) . We determined the tissue expression pattern and transcript size for each EST by Northern analysis of adult human and foetal mRNAs. Figure 3 shows the multiple tissue northern (MTN) blot for EST DKFZp434A139Q2, which represents the 3' end of the human RAI1 gene. This clone was obtained from the German Genome Project. 35 An 8.0 kb transcript is seen in all adult tissues. Table 2 shows the results of our analysis of ESTs that map to the SMS critical interval. Four ESTs, WI-13499, DKFZp434A139Q2, WI-11472, and NIB1041, represent known genes and are described below. Several of the ESTs that we sequenced, including IB1187, stSG8339, D17S2021, T78887, A003A44, A004R11, and A006R41 were novel, or only matched other unidentified clones in the database (Table 2 ). A006R41 is of interest, as this gene is expressed in foetal brain and may play a role in development. A004R11 may possibly represent a metabolic gene, as it is expressed in only adult and foetal liver.
We recently mapped marker stSG26124 through sequence analysis and carried out an initial tissue expression analysis ( Table 2 ). The Unigene database lists stSG26124 as representative of the cDNA for the KIAA0864 protein (GenBank AB020671; Unigene Hs.84883). We obtained a clone for KIAA0864 from the Kazusa Research Institute (Database of Human Unidentified Gene-Encoded Large Protein (HUGE) database; http://www.kazusa.or.jp/huge/gfpage/KIAA0864). The cellular role of this protein is unknown, though preliminary sequence analysis suggests that it may be involved in control of the actin cytoskeleton (Table 2) .
Three ESTs, IB1187, stSG8339 (represented by a single EST), and T78887 did not show transcripts on Northern blot, possibly due to low transcript abundance or expression in tissues not represented on the Clontech MTN and foetal blots ( Table 2 ). There are several known genes within the critical interval that have not been extensively analysed that we consider to be promising SMS candidate genes. These six genes are summarised below:
FLII The Drosophila melanogaster flightless-I (fliI) protein is a member of the gelsolin family of proteins, which play a role in actin binding and severing. 39 FLII, the human homologue of fliI is 58% identical to the Drosophila protein and contains a leucine-rich repeat (LRR) N-terminal domain, which is believed to play a role in cell adhesion and protein ± protein interaction. 40 In Drosophila, less severe mutations in the FLII locus lead to abnormal myofibrillar arrangements in the indirect flight muscles which result in flightlessness; more debilitating mutations are embryonic lethal. 40 FLII (GenBank NM_002018, Unigene Hs. 83849, OMIM 600362) has the ability to bind to actin in vitro and is highly expressed in human muscle, though little else is known about its cellular role. 33 An interacting protein, termed FLAP (FLI-LRR associated protein) has been identified, which may link FLII to the actin cytoskeleton. 33, 41 Genomic clones for human FLII demonstrate that the 3' end of this gene overlaps with the 3' end of the LLGL1 gene. 33 The murine homologue of FLII, Fliih has recently been identified and mapped to mouse chromosome 11B. 42 The 3' overlap region between Fliih and
Llglh is conserved in the mouse. 42 Human FLII was mapped to the SMS critical interval by FISH and somatic cell hybrids and remains a potential candidate gene.
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LLGL1 LLGL1 (GenBank NM_004140, Unigene Hs. 95659, OMIM 600966) is the human homologue of the Drosophila tumour suppressor gene, D-lethal (2) giant larvae. When disrupted, D-lgl can produce tumours in imaginal disks and abnormal transformation of the adult optic centers in larval brains. 43 Human LLGL1 is expressed in brain, kidney, and muscle, and shows an association with the cytoskeleton. 43 Antibodies against LLGL1 were able to co-immunoprecipitate LLGL1 and non-muscle mysosin heavy chain; this interaction is conserved between human and Drosophila. 43 Both
Drosophila and human LLGL1 are also associated with a serine kinase, which is able to specifically recognise and phosphorylate serine residues within the protein. 43 LLGL1 was mapped to chromosome 17p11.2 by FISH and Southern blotting 43 and was demonstrated to overlap at the 3' end with the FLII gene. 33 The contribution of this gene to the SMS phenotype is unknown.
DRG2 Directly adjacent to MYO15A is developmentallyregulated GTP-binding protein 2 (DRG2) (GenBank Transcription map of the SMS critical interval RE Lucas et al 898 NM_001388, Unigene Hs.78582, OMIM 602986). The DRG2 protein is a member of a novel family of small GTP-binding proteins that are highly conserved and may play a role in oncogenesis. 44 DRG2 is highly homologous to DRG1, a developmentally regulated gene that is expressed in embryonic and neoplastic tissue and down-regulated in adult tissues. 45, 46 Northern analysis of DRG2 shows low levels of expression in all adult and foetal tissues examined. 30, 44 This preliminary evidence suggests that DRG2 is not developmentally regulated, but further studies are required. The role of DRG2 in SMS, if any, is unknown.
RAI1
In this study, we have mapped RAI1 (GenBank NM_030665, Unigene Hs.278684) by HTGS analysis to the central portion of the SMS critical interval. We confirmed our sequence analysis by Southern hybridisation of the 3' end of the human RAI1 gene to the somatic cell hybrid mapping panel ( Figure 2 ). This result demonstrated that RAI1 is deleted in all SMS patients. RAI1 (retinoic acid-induced 1) is the human homolog of the mouse GT1 gene, which is up-regulated in mouse embryonal carcinoma cells following retinoic acid treatment to induce neuronal differentiation. 47 In situ hybridisation demonstrated that GT1 protein expression in mouse brain is localised to neurons. 47 A recent study revealed that the human RAI1 protein, which contains a CAG repeat, may modify the age of onset of spinocerebellar ataxia type 2 (SCA2) possibly through a protein-protein interaction involving the polyglutamine regions of the ataxin-2 and RAI1 proteins. 48 As GT1 shows ubiquitous expression in brain and may influence neuronal differentiation, 47 additional studies are required to assess the role of RAI1 in the SMS phenotype. Northern analysis indicates that human RAI1 is expressed as an 8.0 kb transcript in all adult tissues (Table 2 and Figure 3 ). As this manuscript was under review, Seranski et al.
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published the genomic structure of RAI1 and determined the expression pattern of RAI1 by Northern analysis; these results are in agreement with Figure 3 .
RASD1 (formerly AGS1/DEXRAS1) We previously localised the EST marker NIB1041 to the SMS critical interval by PCR to somatic cell hybrids. 8 Recent sequence analysis in our laboratory has determined that the~1.5 kb NIB1041 insert is a 99% match to 3' end of cDNA sequence for activator of Gsignalling 1 (AGS1) (GenBank AF222979, Unigene Hs.25829) as well as the cDNA sequence for dexamethasone-induced ras-related protein (DEXRAS1) (GenBank AF262018, Unigene Hs.25829). Unigene has grouped AGS1 and DEXRAS1 together in the same entry, indicating that these sequences represent the same gene, now formally designated RASD1. AGS1 (activator of G-protein signalling), was isolated through a Saccharomyces cerevisiae screen to identify mammalian nonreceptor activators of G-protein signaling pathways. 50 AGS1, a ras-related protein, is able to process guanosine triphosphate exchange of the heterotrimeric G protein G a subunit. 50.51 DexRas1 was discovered independently in mice through differential display analysis to identify genes that were induced by glucocorticoid hormone (dexamethasone) treatment in AtT-20 cells. 52 Murine DexRas1 is expressed in heart, brain, and liver, and DEXRAS1 mRNA levels in these tissues significantly increased after glucocorticoid treatment. 52 Human DEXRAS1 cDNA was isolated through a yeast two-hybrid screen and subsequently cloned. 53 The mouse and human DEXRAS1 protein are 98% identical at the amino acid level and both are members of the Ras superfamily of GTPases. 53 Expression of human DEXRAS1
was also shown to be strongly stimulated by dexamethasone, in a variety of tissues ( Table 2 , in agreement with our NIB1041 data). 53 Recent investigation into the role of rat Dexras1 in signalling demonstrates a ternary complex formation between neuronal nitric acid synthase (nNOS), the nNOS adaptor protein CAPON and Dexras1 to enhance Dexras1 GTP/GDP exchange. 54 The downstream signalling targets of Dexras1 are unknown. 54 Human DEXRAS1 may also play a role in cell adhesion and extracellular matrix interactions, 53 though the contribution to the SMS phenotype is unknown.
NT5M (dNT-2) Our BLAST searches of the~2.1 kb insert of EST WI-11472 revealed that WI-11472 is a 99% match to the cDNA for deoxyribonucleotidase-2 (dNT-2/NT5M) (GenBank NM_020201, Unigene Hs.16614), which codes for a mitochondrial deoxyribonucleotidase. 31 Independently, Rampazzo et al. 31 mapped NT5M to the SMS region based on sequence analysis of a genomic clone (GenBank AC006071) and the proximity of NT5M to COPS3. Deoxyribonucleotidases hydrolyze the monophosphate ester linkages of the 5' or 3' carbon of deoxyribonucleotides, producing an inorganic phosphate and the corresponding deoxyribonucleoside. 55 Northern analysis of NT5M revealed high expression in the heart, brain, and skeletal muscle, à typical' pattern for a mitochondrial enzyme. 31 These data are in agreement with our Northern analysis of EST WI-11472 ( Table 2 ). The authors demonstrated that NT5M is targetted to the mitochondria by GFP-fusion localisation and by in vitro incubation of the recombinant protein with mitochondria. 31 NT5M activity is limited to the dephosphorylation of thymine and uracil deoxyribonucleotides and may play an important role in modulation of dTTP substrate pools and removal of excess dTTP from the mitochondria. 31 A potential role in SMS is yet to be identified.
Discussion
In order to identify possible candidates for SMS and to characterise the genomic content of distal 17p11.2, we sought to create the first contiguous physical and transcription map of the SMS critical region. Given the increased stability in the case of manipulation of BACs and PACs compared to yeast artificial chromosomes (YACs), we chose
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BACs and PACs to complete the contig of the SMS critical interval. As well, given that the human genome sequence was being determined using BAC and PAC library clones, our mapping information will be invaluable in validating the draft sequence. We also relied on previously-published maps of the region, 14,17 including a partial YAC contig, to confirm the placement of markers, although many discrepancies existed between various maps for the localisation of certain genes and STSs. An example of conflicting data is the mapping of marker D17S258 in the YAC contig and in our current map. 14 We localised this marker, by sequence analysis and by hybridisation, adjacent to SREBF1, within the SMS critical interval. Chen et al. 14 localised this marker in a more centromeric position, adjacent to D17S29. Furthermore, an earlier, preliminary transcription map of chromosome 17p11.2, generated in order to identify regions of chromosomal instability contains many gaps that we have subsequently filled. 17 Our current contig also differs somewhat from the published human draft sequence by the Human Genome Sequencing Consortium. 56 The latter map separates the overlapping genes FLII and LLGL1 33 and places several genes between them, including ALDH3, ALHD10, and MFAP4, which have been previously localised to a more proximal region of 17p11.2. 8 In our transcription map, we rearranged several markers and confirmed their order from the telomeric to centromeric regions of 17p11.2 ( Figure 1 ). In order to identify possible SMS candidate genes, we are especially interested in genes that are developmentallyregulated and those that may play a role in mental and behavioural development. In addition, genes that are expressed in the neural crest could affect craniofacial and heart development. 57 ± 59 We are also very interested in transcription factors, as they may have a more global effect on development and are often dosage-sensitive. 60, 61 The Tbox family transcription factor TBX1 was recently identified as the gene responsible for the cardiac defects in DiGeorge syndrome, a disorder resulting from a microdeletion involving 22q11. 60 ± 62 As discussed in depth above, genes that are of high priority for further study are RAI1, FLII, LLGL1, DRG2, RASD1, and NT5M. NT5M is an especially intriguing SMS candidate gene because of the possible role of the NT5M protein on the modulation of dTTP substrate pools in the mitochondria. 31 We speculate that some of the characteristics of SMS, including hypotonia, mental retardation, and behavioural abnormalities, may be an effect of excess dTTP and defective mitochondria. Furthermore, modulation of nucleotide metabolism has been shown to be important in disorders with similar physical and behavioural features to SMS, such as Lesch-Nyhan syndrome. 63, 64 We also consider the nine novel ESTs to be possible candidate genes, especially EST A006R41, as it is expressed in foetal brain (Table 2) . In this study, we have generated the first overlapping and contiguous transcription map of the entire SMS critical interval, linking the proximal 17p11.2 region near the SMS-REPM and the distal region near D17S740 in a minimum tiling path of 16 BACs and two PACs. As the presence of lowcopy repeats and duplicons that flank this region can make sequence alignment difficult, and some of the information from the human genome project was inconsistent with naturally-occurring deletions described in patients, 7, 8 we combined sequence analysis with molecular biological techniques such as PCR and Southern analysis to give our map greater coverage. Concurrently, we were able to identify six promising SMS candidate genes and numerous ESTs that warrant further investigation. We intend to pursue mouse knockout models and in depth in vitro characterisation of these genes and ESTs, including analysis in SMS patient and parental control cell lines.
